Abstract
Autoantibodies against Nε-carboxymethyl lysine and methylglyoxal modified albumin are associated with cardiovascular risk in type 2 diabetes
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have